Skip to main contentSkip to navigation
Sirius Investors
Vimian Group AB (publ)

Vimian Group AB (publ)

VIMGF
OTCHealthcare

Vimian Group AB (publ) (VIMGF) Investment Research Dashboard

About Vimian Group AB (publ) (VIMGF) stock analysis

Get live VIMGF stock price $2.77, comprehensive Vimian Group AB (publ) stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time VIMGF stock data and investment insights.

2.77
0.00%Today
Market Cap
1.46B
Volume
7.00K
52W High
4.30
52W Low
2.68

Loading chart data...

Vimian Group AB (publ) (VIMGF) Overview

Vimian Group AB (publ) (VIMGF) is a publicly traded company in the Healthcare sector , specifically within the Medical - Diagnostics & Research industry . As of the latest trading session, VIMGF trades at $2.77 with a market capitalization of 1.46B . Over the past 52 weeks, VIMGF has traded between $2.68 and $4.30 , with the current price positioned at approximately 6% of this range . The stock...

Key Takeaways

  • Operates in the Healthcare sector (Medical - Diagnostics & Research)
  • Market cap: 1.46B
  • Current price: $2.77
  • 52-week range: $2.68 - $4.30
  • P/E ratio: 31.62

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Vimian Group AB (publ) is an international enterprise focused on the animal health sector, organized into four distinct divisions: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services. The company offers a range of proprietary diagnostic t...

Company Information

CEO
Alireza Tajbakhsh
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
1300

Contact Information

Address
Riddargatan 19
Country
SE

Investment Analysis & Business Insights

Healthcare
Medical - Diagnostics & Research

Investment Highlights

Strong presence in the Healthcare sector with established market position

Growth-oriented company with premium valuation (P/E: 31.6)

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Vimian Group AB (publ) shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Vimian Group AB (publ)
  • Investors should consider how Vimian Group AB (publ) fits within their overall portfolio allocation
  • Premium valuation (P/E: 31.6) requires strong growth to justify

Market Cap

1.46B

P/E Ratio (TTM)

31.62

Beta

1.17

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

80/100 ⭐⭐⭐⭐⭐

Overall
+0.7%
NYSE
+0.6%
NASDAQ
+0.7%
Sector1D1W1MP/EScore
Financial Services+2.2%+5.7%+6.1%19.3
98/100⭐⭐⭐⭐⭐
Communication Services+1.4%+2.9%+4.3%22.2
86/100⭐⭐⭐⭐⭐
Healthcare+0.7%+3.3%+3.5%24.1
80/100⭐⭐⭐⭐⭐
Basic Materials+0.4%+1.1%-0.2%25.2
56/100⭐⭐⭐⭐
Consumer Defensive-0.2%+1.7%+1.2%29.7
56/100⭐⭐⭐⭐
Real Estate-0.5%-0.1%-1.6%29.2
43/100⭐⭐⭐
Energy-2.1%-5.8%-5.1%19.1
39/100⭐⭐
Utilities-1.0%-3.0%-5.9%26.8
28/100⭐⭐
Industrials+0.6%+1.7%-11.2%30.1
26/100⭐⭐
Consumer Cyclical+0.5%-0.4%-6.3%43.0
21/100
Technology+0.6%-2.3%-9.6%40.7
17/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.